In Vitro Drug Articles & Analysis
12 news found
This critical step in the drug development process refers to the systematic evaluation of the safety of therapeutic drugs through laboratory studies and animals in vitro. ...
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has recently launched its new line of PLGA-based drug delivery systems for in vitro and in vivo applications, including biocompatible and biodegradable PLGA nanoparticles with different surface modifications (e.g., COOH groups, methoxy PEG, and PEG-azide). ...
Various aspects such as the route of administration, dosage form, maximum and minimum doses, and the appearance of drug carriers, would be taken into consideration to achieve the most efficient and effective drug delivery. ...
These results solve the critical issue of CTC rarity and pave the way for their use in early diagnostics of cancer, prognostics, theranostics, and in vitro personalized drug efficacy tests, including through CTC culture. ...
There is an intense need for more accurate screening methods during preclinical studies using in vitro assays that more closely mimic in vivo conditions. Currently, only 12% of drugs that begin phase 1 clinical trials move on to eventually receive FDA approval. ...
Cairn Diagnostics, an innovative leader in providing cutting-edge breath tests intended for routine use in diagnostic medicine, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of the Company’s 13C-Spirulina Gastric Emptying Breath Test (GEBT) to now include “at home” administration under virtual supervision of Cairn ...
Study Results The study evaluated the in vitro drug release and in vivo pharmacokinetics of novel XTreo™ MF matrices in a rabbit dorsal maxillary osteotomy model. ...
Drug discovery is often a laborious, and time-consuming task. Now, Creative Biolabs has optimized a portfolio of antiviral drug discovery services, especially neutralizing antibody development for SARS-CoV-2. As one of the well-recognized experts who are professional in antibody development, Creative Biolabs has built a variety of antibody development platforms, ...
About Oligomerix’s Lead Program Oligomerix’s lead candidate is a small molecule inhibitor of tau self-association and targets the beginning of the tau aggregation cascade. The activity of the drug translated from in vitro and cell assays to animal studies, validating the company’s screening approach. ...
ImmunoCAP Specific IgE alpha-Gal Allergen Component test has been cleared by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use. Test results can aid specialists and other healthcare providers as they diagnose a patient's sensitization to the alpha-Gal carbohydrate found in mammalian (red) meat and assess his or her risk for an anaphylactic ...
ImmunoCAP Specific IgE Stinging Insect Allergen Components have been cleared by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use. Results from these component tests can act as a diagnostic aid to help specialists and other healthcare providers discriminate between true sensitization and cross reactivity, identify culprit insect(s) in ...
The companies, funded by NSF and focused on drug discovery, diagnostics and other platform technologies, will participate in a dedicated track of company presentations. ...